SpeculatingStocks.com: Stock Picks, Stock Analysis and Stock Updates Daily
Enter your Email Address for Stock Alerts Intraday Stock Updates
SpeculatingStocks.com Homepage Stock Market Services Offered Our Winning Stock Pick Success
Stock Picks


Stock Notes
Stock Updates on Past Stock Picks
Speculation Board
Testimonials from Viewers
The SpeculatingStocks.com Team
Contact us and More Info
Purchase a Stock Picks Package
SpeculatingStocks.com Press and Media Page for Stock Market / Stock Information
  

January 30th, 2008

SpeculatingStocks.com Stock Pick: Geron Corporation (GERN)

Stock Price: $5.15

Geron Corporation is a biopharmaceutical company developing therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes, and HIV/AIDS. The company is developing human embryonic stem cell therapies, including GRNOPC1, which contains oligodendroglial progenitor cells targeted for the treatment of spinal cord injury.

GERN could benefit from the upcoming presidential elections. Greater stem cell funding and support could be on its way creating a more positive environment for GERN to operate.

GERN is one of the more well known stem cell development companies and trading at a market cap of only around $388 million.

GERN has a very strong balance sheet with over $208 million in cash and short-term investments on the balance sheet and no long-term debt and total liabilities of only $12.46 million.

We believe GERN will start living up to its potential. GERN's next catalyst may come from FDA approval for GERN to start clinical trials on a stem cell treatment for spinal cord injuries.

Please Read our Legal Disclaimer Our Privacy Policy